Nisa Investment Advisors LLC Buys 751 Shares of Teleflex Incorporated (NYSE:TFX)

Nisa Investment Advisors LLC grew its stake in Teleflex Incorporated (NYSE:TFX) by 6.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 11,912 shares of the medical technology company’s stock after acquiring an additional 751 shares during the period. Nisa Investment Advisors LLC’s holdings in Teleflex were worth $2,970,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of TFX. Cambridge Investment Research Advisors Inc. lifted its holdings in Teleflex by 2.5% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,231 shares of the medical technology company’s stock valued at $792,000 after purchasing an additional 54 shares during the last quarter. HighTower Advisors LLC lifted its holdings in Teleflex by 2.2% during the 1st quarter. HighTower Advisors LLC now owns 4,678 shares of the medical technology company’s stock valued at $1,655,000 after purchasing an additional 99 shares during the last quarter. Private Advisor Group LLC acquired a new stake in Teleflex during the 1st quarter valued at $455,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in Teleflex by 6.6% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,268 shares of the medical technology company’s stock valued at $2,224,000 after purchasing an additional 388 shares during the last quarter. Finally, Yousif Capital Management LLC lifted its holdings in Teleflex by 2.7% during the 1st quarter. Yousif Capital Management LLC now owns 7,158 shares of the medical technology company’s stock valued at $2,540,000 after purchasing an additional 190 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total value of $1,665,225.00. Following the sale, the vice president now owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.41% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Royal Bank of Canada lowered their price objective on Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. Truist Financial lowered their price objective on Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a research report on Friday, February 23rd. JMP Securities reiterated a “market outperform” rating and set a $285.00 price objective on shares of Teleflex in a research report on Friday, February 23rd. Raymond James increased their price objective on Teleflex from $227.00 to $271.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 20th. Finally, StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Teleflex currently has an average rating of “Moderate Buy” and a consensus price target of $265.56.

Teleflex Stock Down 1.3 %

Shares of NYSE TFX opened at $214.50 on Friday. Teleflex Incorporated has a one year low of $177.63 and a one year high of $276.43. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.32 and a quick ratio of 1.29. The business’s fifty day moving average price is $229.64 and its 200-day moving average price is $224.77. The stock has a market capitalization of $10.10 billion, a PE ratio of 28.49, a P/E/G ratio of 2.08 and a beta of 1.11.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.26 by $0.12. The business had revenue of $773.90 million for the quarter, compared to analysts’ expectations of $769.01 million. Teleflex had a return on equity of 14.98% and a net margin of 11.98%. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.52 EPS. On average, equities research analysts anticipate that Teleflex Incorporated will post 13.73 EPS for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $1.36 dividend on an annualized basis and a yield of 0.63%. Teleflex’s dividend payout ratio (DPR) is 18.06%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.